%0 Journal Article %A Fiona Aanesen %A Margreth Grotle %A Tarjei Langseth Rysstad %A Anne Therese Tveter %A Alexander Tingulstad %A Ida Løchting %A Milada C Småstuen %A Maurits W van Tulder %A Rigmor Berg %A Nadine E Foster %A Gwenllian Wynne-Jones %A Gail Sowden %A Egil Fors %A Gunnhild Bagøien %A Roger Hagen %A Kjersti Storheim %A Britt Elin Øiestad %T Effectiveness of adding motivational interviewing or a stratified vocational advice intervention to usual case management on return to work for people with musculoskeletal disorders: the MI-NAV randomised controlled trial %D 2023 %R 10.1136/oemed-2022-108637 %J Occupational and Environmental Medicine %P 42-50 %V 80 %N 1 %X Objectives To evaluate if adding motivational interviewing (MI) or a stratified vocational advice intervention (SVAI) to usual case management (UC), reduced sickness absence over 6 months for workers on sick leave due to musculoskeletal disorders.Methods We conducted a three-arm parallel pragmatic randomised controlled trial including 514 employed workers (57% women, median age 49 (range 24–66)), on sick leave for at least 50% of their contracted work hours for ≥7 weeks. All participants received UC. In addition, those randomised to UC+MI were offered two MI sessions from social insurance caseworkers and those randomised to UC+SVAI were offered vocational advice from physiotherapists (participants with low/medium-risk for long-term sickness absence were offered one to two sessions, and those with high-risk were offered three to four sessions).Results Median sickness absence was 62 days, (95% CI 52 to 71) in the UC arm (n=171), 56 days (95% CI 43 to 70) in the UC+MI arm (n=169) and 49 days (95% CI 38 to 60) in the UC+SVAI arm (n=169). After adjusting for predefined potential confounding factors, the results showed seven fewer days in the UC+MI arm (95% CI −15 to 2) and the UC+SVAI arm (95% CI −16 to 1), compared with the UC arm. The adjusted differences were not statistically significant.Conclusions The MI-NAV trial did not show effect on return to work of adding MI or SVAI to UC. The reduction in sickness absence over 6 months was smaller than anticipated, and uncertain due to wide CIs.Trial registration number NCT03871712.Data are available upon reasonable request. Requests to access data should be addressed to the last author: brielo@oslomet.no. Anonymised individual participant data (including data dictionary) will be available on request, from January 2023 to December 2028, to researchers who provide a methodologically sound scientific proposal that has been approved by an ethics committee and by the scientific board of the MI-NAV study. %U https://oem.bmj.com/content/oemed/80/1/42.full.pdf